Comments

ArriVent BioPharma Stock Price, Quotes and Forecasts

Q: What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

AVBPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$18.99

-1.22-6.04%

At close: -

$18.99

0.000.00%

After Hours: 4:00 PM EDT

ArriVent BioPharma (AVBP) Forecast

News Earnings ArriVent BioPharma (AVBP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

ArriVent BioPharma Stock Price, Quotes and Forecasts | NASDAQ:AVBP | Benzinga

Explore ArriVent BioPharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AVBP.

Open	$20.12
Close	$18.99
Volume / Avg.	214.18K / 162.36K
Day Range	$18.58 - $20.15
52 Wk Range	14.35 - 36.37
Market Cap	$645.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	15.37%
Days to Cover	20.16

Recent News

ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside

B. Riley initiates coverage on ArriVent Biopharma, citing firmonertinib's potential in NSCLC. The analyst sees strong upside with a $37 price target.

Vandana Singh

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$20.12
Close	$18.99
Volume / Avg.	214.18K / 162.36K
Day Range	$18.58 - $20.15
52 Wk Range	14.35 - 36.37
Market Cap	$645.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	15.37%
Days to Cover	20.16

About ArriVent BioPharma Inc.

Sector

Health Care

Industry

Biotechnology

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ArriVent BioPharma (AVBP) stock?

You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.

View our list of the best stock brokerages

Who are ArriVent BioPharma (AVBP) competitors?

Other companies in ArriVent BioPharma’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Cogent Biosciences (NASDAQ:COGT).

What is the forecast, or price target, for ArriVent BioPharma (AVBP) stock?

ArriVent BioPharma has a consensus price target of $38.43.

What is the current price for ArriVent BioPharma (AVBP)?

The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $18.99 last updated March 25, 2025 at 4:00 PM EDT.

Does ArriVent BioPharma (AVBP) pay a dividend?

There are no upcoming dividends for ArriVent BioPharma.

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

ArriVent BioPharma’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is ArriVent BioPharma (AVBP) going to split?

There is no upcoming split for ArriVent BioPharma.

What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.